Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

BACKGROUND: Dipeptidyl-peptidase-4 inhibitors (DPP4Is) are drugs for the treatment of type 2 diabetes mellitus (T2DM). There is increasing evidence that DPP4Is may result in suppression of the immune system and may increase the risk of infections such as pneumonia. Aim of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Wvan der Zanden, Rogier, de Vries, Frank, Lalmohamed, Arief, Driessen, Johanna H. M., de Boer, Anthonius, Rohde, Gernot, Neef, Cees, den Heijer, Casper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607497/
https://www.ncbi.nlm.nih.gov/pubmed/26468883
http://dx.doi.org/10.1371/journal.pone.0139367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607497/
https://www.ncbi.nlm.nih.gov/pubmed/26468883
http://dx.doi.org/10.1371/journal.pone.0139367

Ejemplares similares